MetaCap

Who Owns Ascendis Pharma A/S Stock?

NASDAQ: ASNDHealth CareBiotechnology: Pharmaceutical PreparationsUSD

252.73-3.23 (-1.26%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
101.00%
Institutional holders
487
  • Institutions 99.1%
  • Insiders 0.9%
  • Public and other 0.0%

Who owns Ascendis Pharma A/S stock?

Institutional investors own about 101.0% of Ascendis Pharma A/S's shares, spread across 487 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 0.90% of ASND.

The largest institutional holders are RA Capital Management, L.P. (0.00%), T. Rowe Price Investment Management, Inc. (0.00%) and Westfield Capital Management Co LP (0.00%). Together, the top 10 institutions control 0.0% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their ASND positions and 3 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of ASND

Ascendis Pharma A/S top institutional holders
InstitutionShares% HeldChange
RA Capital Management, L.P.10.28M0.00%0.0%
T. Rowe Price Investment Management, Inc.6.75M0.00%+9.6%
Westfield Capital Management Co LP5.13M0.00%+6.8%
Avoro Capital Advisors LLC5.11M0.00%+1.0%
Jupiter Topco LLC3.65M0.00%+100.0%
FMR, LLC3.45M0.00%-2.8%
Artisan Partners Limited Partnership2.63M0.00%-18.5%
Blackrock Inc.2.21M0.00%+234.6%
Massachusetts Financial Services Co.1.90M0.00%+1.1%
Wellington Management Group, LLP1.55M0.00%-11.9%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of ASND

Ascendis Pharma A/S top fund holders
FundShares% Held
T. ROWE PRICE CAPITAL APPRECIATION Fd., INC.-T. Rowe Price Capital App3.36M0.00%
MFS Series Trust IV-MFS Mid Cap Growth Fund1.27M0.00%
VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund1.10M0.00%
Franklin Custodian Funds-FRANKLIN DYNATECH FUND1.00M0.00%
Growth Fund of America894.76K0.00%
JNL Series Trust-JNL/T. Rowe Price Capital Appreciation Fund795.73K0.00%
American Century Mutual Funds, Inc.-ULTRA FUND664.00K0.00%
T. Rowe Price Mid-Cap Growth Fund, Inc.639.11K0.00%
SmallCap World Fund Inc570.65K0.00%
Fidelity Select Portfolios-Select Health Care Portfolio500.00K0.00%

Frequently asked questions

Who is the largest shareholder of Ascendis Pharma A/S?

RA Capital Management, L.P. is the largest institutional shareholder of ASND, owning 0.00% of shares outstanding (10.28M shares) as of its latest 13F filing.

What percentage of Ascendis Pharma A/S is owned by institutions?

Institutions own about 101.0% of ASND shares and 101.9% of the public float.

How much of Ascendis Pharma A/S do insiders own?

Insiders, such as officers and directors, own about 0.90% of ASND shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related